TytoCare Secures FDA De Novo for First AI-Powered Eardrum Analysis

NEW YORK, April 27, 2026 /PRNewswire/ -- TytoCare, a virtual care company enabling accessible, high-quality primary care from home, today announced it has received FDA De Novo classification for the first model of Tyto Insights™ for ENT Suite, marking the creation of a new regulatory category for AI-powered ENT image analysis.

Through the De Novo process, TytoCare has established a first-of-its-kind classification for an “ear, nose, and throat image analyzer,” a new regulatory category. The company has added a new layer to its solution, which uses AI to analyze otoscopy video recordings of the eardrum to aid healthcare providers and patients by detecting eardrum bulging, which is a common sign in Acute Otitis Media and other conditions.

Tyto Insights™ for ENT Suite is designed to automatically detect bulging of the eardrum in otoscopic video recordings captured using TytoCare’s compatible digital otoscope. The solution is intended for patients aged six months and older and provides results to healthcare providers as a clinical support tool, and informs patients about their condition. TytoCare’s proprietary database of 1.6 million ear images and recordings enabled the development of Tyto Insights™ for ENT Suite.

Sign up for Blog Updates